Logo image of RKLB

ROCKET LAB CORP (RKLB) Stock Fundamental Analysis

NASDAQ:RKLB - US7731211089 - Common Stock

48.6 USD
+0.69 (+1.44%)
Last: 8/29/2025, 8:00:01 PM
48.23 USD
-0.37 (-0.76%)
After Hours: 8/29/2025, 8:00:01 PM
Fundamental Rating

3

RKLB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 68 industry peers in the Aerospace & Defense industry. While RKLB seems to be doing ok healthwise, there are quite some concerns on its profitability. RKLB shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RKLB had negative earnings in the past year.
In the past year RKLB has reported a negative cash flow from operations.
RKLB had negative earnings in each of the past 5 years.
In the past 5 years RKLB always reported negative operating cash flow.
RKLB Yearly Net Income VS EBIT VS OCF VS FCFRKLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

RKLB has a Return On Assets of -14.89%. This is in the lower half of the industry: RKLB underperforms 70.59% of its industry peers.
RKLB has a Return On Equity of -33.60%. This is in the lower half of the industry: RKLB underperforms 70.59% of its industry peers.
Industry RankSector Rank
ROA -14.89%
ROE -33.6%
ROIC N/A
ROA(3y)-16.4%
ROA(5y)-18.08%
ROE(3y)-34.28%
ROE(5y)-34.08%
ROIC(3y)N/A
ROIC(5y)N/A
RKLB Yearly ROA, ROE, ROICRKLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

With a decent Gross Margin value of 29.04%, RKLB is doing good in the industry, outperforming 67.65% of the companies in the same industry.
RKLB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RKLB Yearly Profit, Operating, Gross MarginsRKLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

5

2. Health

2.1 Basic Checks

RKLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
RKLB has more shares outstanding than it did 1 year ago.
RKLB has more shares outstanding than it did 5 years ago.
The debt/assets ratio for RKLB is higher compared to a year ago.
RKLB Yearly Shares OutstandingRKLB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
RKLB Yearly Total Debt VS Total AssetsRKLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 15.53 indicates that RKLB is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 15.53, RKLB belongs to the best of the industry, outperforming 95.59% of the companies in the same industry.
A Debt/Equity ratio of 0.60 indicates that RKLB is somewhat dependend on debt financing.
RKLB's Debt to Equity ratio of 0.60 is in line compared to the rest of the industry. RKLB outperforms 44.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Altman-Z 15.53
ROIC/WACCN/A
WACC9.94%
RKLB Yearly LT Debt VS Equity VS FCFRKLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

RKLB has a Current Ratio of 2.67. This indicates that RKLB is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.67, RKLB perfoms like the industry average, outperforming 54.41% of the companies in the same industry.
A Quick Ratio of 2.33 indicates that RKLB has no problem at all paying its short term obligations.
RKLB has a better Quick ratio (2.33) than 72.06% of its industry peers.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2.33
RKLB Yearly Current Assets VS Current LiabilitesRKLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

7

3. Growth

3.1 Past

RKLB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.57%.
RKLB shows a strong growth in Revenue. In the last year, the Revenue has grown by 54.37%.
Measured over the past years, RKLB shows a very strong growth in Revenue. The Revenue has been growing by 55.23% on average per year.
EPS 1Y (TTM)-28.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-62.5%
Revenue 1Y (TTM)54.37%
Revenue growth 3Y91.41%
Revenue growth 5Y55.23%
Sales Q2Q%36%

3.2 Future

The Earnings Per Share is expected to grow by 32.40% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 32.13% on average over the next years. This is a very strong growth
EPS Next Y-16.61%
EPS Next 2Y27.89%
EPS Next 3Y31.1%
EPS Next 5Y32.4%
Revenue Next Year34.29%
Revenue Next 2Y43.15%
Revenue Next 3Y40.51%
Revenue Next 5Y32.13%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RKLB Yearly Revenue VS EstimatesRKLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
RKLB Yearly EPS VS EstimatesRKLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RKLB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RKLB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RKLB Price Earnings VS Forward Price EarningsRKLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RKLB Per share dataRKLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

RKLB's earnings are expected to grow with 31.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.89%
EPS Next 3Y31.1%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RKLB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROCKET LAB CORP

NASDAQ:RKLB (8/29/2025, 8:00:01 PM)

After market: 48.23 -0.37 (-0.76%)

48.6

+0.69 (+1.44%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners61.47%
Inst Owner Change6.48%
Ins Owners0.68%
Ins Owner Change-5.1%
Market Cap23.45B
Analysts80
Price Target45.77 (-5.82%)
Short Float %11.27%
Short Ratio2.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.65%
Min EPS beat(2)-11.38%
Max EPS beat(2)8.09%
EPS beat(4)3
Avg EPS beat(4)3.2%
Min EPS beat(4)-11.38%
Max EPS beat(4)12.21%
EPS beat(8)7
Avg EPS beat(8)8.2%
EPS beat(12)8
Avg EPS beat(12)4.25%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.82%
Min Revenue beat(2)-0.99%
Max Revenue beat(2)4.63%
Revenue beat(4)2
Avg Revenue beat(4)0.87%
Min Revenue beat(4)-0.99%
Max Revenue beat(4)4.63%
Revenue beat(8)2
Avg Revenue beat(8)-1.29%
Revenue beat(12)5
Avg Revenue beat(12)-0.34%
Revenue beat(16)8
Avg Revenue beat(16)1.42%
PT rev (1m)21.42%
PT rev (3m)82.38%
EPS NQ rev (1m)-6.84%
EPS NQ rev (3m)-79.11%
EPS NY rev (1m)-5.35%
EPS NY rev (3m)-6.55%
Revenue NQ rev (1m)0.18%
Revenue NQ rev (3m)-3.18%
Revenue NY rev (1m)1.46%
Revenue NY rev (3m)0.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 46.49
P/FCF N/A
P/OCF N/A
P/B 34.05
P/tB 41.6
EV/EBITDA N/A
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS1.05
BVpS1.43
TBVpS1.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.89%
ROE -33.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.04%
FCFM N/A
ROA(3y)-16.4%
ROA(5y)-18.08%
ROE(3y)-34.28%
ROE(5y)-34.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 268.86%
Cap/Sales 18.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.67
Quick Ratio 2.33
Altman-Z 15.53
F-Score4
WACC9.94%
ROIC/WACCN/A
Cap/Depr(3y)174.96%
Cap/Depr(5y)206.2%
Cap/Sales(3y)19.28%
Cap/Sales(5y)34.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-62.5%
EPS Next Y-16.61%
EPS Next 2Y27.89%
EPS Next 3Y31.1%
EPS Next 5Y32.4%
Revenue 1Y (TTM)54.37%
Revenue growth 3Y91.41%
Revenue growth 5Y55.23%
Sales Q2Q%36%
Revenue Next Year34.29%
Revenue Next 2Y43.15%
Revenue Next 3Y40.51%
Revenue Next 5Y32.13%
EBIT growth 1Y-28.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.45%
EBIT Next 3Y44.65%
EBIT Next 5Y31.86%
FCF growth 1Y-70.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.93%
OCF growth 3YN/A
OCF growth 5YN/A